VIEMED HEALTHCARE, INC. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Viemed Healthcare, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2018 to Q2 2024.
  • Viemed Healthcare, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was $1.47M, a 37% decline year-over-year.
  • Viemed Healthcare, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was $9.47M, a 29% increase year-over-year.
  • Viemed Healthcare, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was $10.2M, a 64.6% increase from 2022.
  • Viemed Healthcare, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was $6.22M, a 31.8% decline from 2021.
  • Viemed Healthcare, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was $9.13M, a 71.1% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $9.47M $1.47M -$862K -37% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $10.3M $1.6M +$86K +5.67% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $10.2M $3.48M +$1.04M +42.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-06
Q3 2023 $9.2M $2.92M +$1.86M +177% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-01
Q2 2023 $7.34M $2.33M +$1.36M +141% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $5.98M $1.52M -$245K -13.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-06
Q4 2022 $6.22M $2.44M -$1.65M -40.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-06
Q3 2022 $7.87M $1.06M -$734K -41% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 $8.61M $967K -$599K -38.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-01
Q1 2022 $9.2M $1.76M +$78K +4.63% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-01
Q4 2021 $9.13M $4.09M -$984K -19.4% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-02
Q3 2021 $10.1M $1.79M -$1.02M -36.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-01
Q2 2021 $11.1M $1.57M -$17.8M -91.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-01
Q1 2021 $29M $1.68M -$2.56M -60.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-01
Q4 2020 $31.5M $5.07M +$2.68M +112% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-03
Q3 2020 $28.8M $2.8M -$49K -1.72% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-02
Q2 2020 $28.9M $19.4M +$18.1M +1364% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-02
Q1 2020 $10.8M $4.24M +$2.29M +117% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-02
Q4 2019 $8.53M $2.39M -$580K -19.5% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-03
Q3 2019 $9.11M $2.85M +$634K +28.6% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-03
Q2 2019 $8.47M $1.33M -$772K -36.8% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-03
Q1 2019 $9.24M $1.96M -$265K -11.9% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-03
Q4 2018 $9.51M $2.97M Oct 1, 2018 Dec 31, 2018 10-K 2020-03-04
Q3 2018 $2.22M Jul 1, 2018 Sep 30, 2018 10-K 2020-03-04
Q2 2018 $2.1M Apr 1, 2018 Jun 30, 2018 10-K 2020-03-04
Q1 2018 $2.22M Jan 1, 2018 Mar 31, 2018 10-K 2020-03-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.